Processing

Please wait...

PATENTSCOPE will be unavailable a few hours for maintenance reason on Tuesday 25.01.2022 at 12:00 PM CET
Settings

Settings

Goto Application

1. WO2022005056 - PHARMACEUTICAL COMPOSITION OR HEALTH FUNCTIONAL FOOD FOR PREVENTION AND TREATMENT OF OBESITY CONTAINING POWDER OF NOVEL HYBRID MUSHROOM AS ACTIVE INGREDIENT

Publication Number WO/2022/005056
Publication Date 06.01.2022
International Application No. PCT/KR2021/007554
International Filing Date 16.06.2021
IPC
A61K 36/06 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
06Fungi, e.g. yeasts
A61P 3/04 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
3Drugs for disorders of the metabolism
04Anorexiants; Antiobesity agents
A61P 1/16 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
1Drugs for disorders of the alimentary tract or the digestive system
16for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
Applicants
  • 주식회사 노바셀테크놀로지 NOVACELL TECHNOLOGY INC. [KR]/[KR]
Inventors
  • 이태훈 LEE, Tae Hoon
  • 김재왕 GHIM, Jae Wang
Agents
  • 한윤호 HAN, Yun Ho
Priority Data
10-2020-007917129.06.2020KR
Publication Language Korean (ko)
Filing Language Korean (KO)
Designated States
Title
(EN) PHARMACEUTICAL COMPOSITION OR HEALTH FUNCTIONAL FOOD FOR PREVENTION AND TREATMENT OF OBESITY CONTAINING POWDER OF NOVEL HYBRID MUSHROOM AS ACTIVE INGREDIENT
(FR) COMPOSITION PHARMACEUTIQUE OU ALIMENT SANTÉ FONCTIONNEL POUR LA PRÉVENTION ET LE TRAITEMENT DE L'OBÉSITÉ CONTENANT DE LA POUDRE D'UN NOUVEAU CHAMPIGNON HYBRIDE UTILISÉ COMME PRINCIPE ACTIF
(KO) 신규 교잡품종 버섯의 분말을 유효성분으로 함유하는 비만 예방 및 치료용 약학적 조성물 또는 건강기능성식품
Abstract
(EN) The present invention provides a pharmaceutical composition for the treatment of obesity and fatty liver disease caused due to a high-fat diet, containing, as an active ingredient, the powder of a fruiting body or a mycelium of hybrid mushroom strain GBN2WP0970 having no side effects and an excellent triglyceride absorption inhibitory effect.
(FR) La présente invention concerne une composition pharmaceutique pour le traitement de l'obésité et de la stéatose hépatique provoquée par un régime riche en graisses, contenant, comme principe actif, de la poudre d'un organe de fructification ou d'un mycélium de la souche de champignon hybride GBN2WP0970 n'ayant pas d'effets secondaires et un excellent effet d'inhibition de l'absorption des triglycérides.
(KO) 본 발명은 부작용이 없고 중성지방 흡수 저해 효과가 우수한 교잡품종 버섯 균주 GBN2WP0970의 자실체 또는 균사체의 분말을 유효성분으로 함유하는, 고지방식이에 따른 비만 및 지방간 질환 치료용 약학적 조성물을 제공한다.
Latest bibliographic data on file with the International Bureau